web analytics
0.3 C
Munich
Saturday, December 3, 2022

The Stars Aligned for Ekso Bionics Holdings, Inc. (OTCBB: EKSO)

Ekso Bionics Holdings, Inc. (OTCBB: EKSO) is a fascinating story developing in small caps that has recently transformed into the top traded stock on the entire exchange with an eye on bigger things.

There are plenty of reasons to get excited about EKSO here; the Company is an early innovator and sits at the forefront of the rapidly growing bionic exoskeleton industry. Word is EKSO is readying itself to apply to up list to a higher exchange and the Company has been busy signing partnerships with key technological players including a recent contract with Google’s Boston Dynamics division to work on a DARPA project.

EKSO may trade on the OTCBB but the Company operates more like a Big Board Stock than a microcap. Since inception there has been no known promotion of EKSO yet the stock trades millions. As well the Company has the proven ability to raise large sums of money; EKSO went public through a reverse merger in January of last year, simultaneously raising $20.6 million through a bridge debt transaction.

EKSO initially hit the bb’s in February 2014 at around $2.50 per share, quickly exploding over $8 before dropping significantly hitting an all-time low of $0.753 in September before embarking on another upward climb.

The current run on EKSO is being powered by positive investor sentiment as the Company advances on a number of fronts as well as overly optimistic Seeking Alpha articles and a 19 page report from Keith Fitz-Gerald’s Total Wealth unstoppable trend report that touts ”How to tap into a $17 billion trend for just $1.00 a share.

Ekso Bionics Holdings, Inc. (OTC: EKSO) has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company’s first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.

Originally Berkeley Bionics, Ekso Bionics was founded in Berkeley, California in 2005. Since inception Ekso Bionics has forged partnerships with world-class institutions like UC Berkeley, received research grants from the Department of Defense and licensed technology to the Lockheed Martin Corporation.

For more info on EKSO Please Subscribe below, also you should know we have Something Huge Coming!

Lockheed Martin is the exclusive contractor of the US military, EKSO is working with them in an attempt to provide exoskeletons for military purposes. Many EKSO investors are overlooking this opportunity. The military market could be the secondary market that not only raises awareness of EKSO’s bionic skeleton, but also advances the function of the technology.

In November 2014, the Company completed a warrant solicitation in which holders of warrants to purchase 22.8 million shares of our common stock elected to exercise their $2.00 warrants at a reduced exercise price of $1.00 per share, providing us with $21.4 million in net proceeds. The Company ended the fourth quarter with cash and cash equivalents of $25.2 million.

CEO Nathan Harding said after the Company released 2014 results ”Thanks to the hard work of all at Ekso Bionics and the support of our many customers and stakeholders, I am excited about the progress we made in our first year as a public company and towards leading this young exoskeleton industry to its full potential. This is thanks to the strong growth of all our businesses: year over year shipments of medical devices in Europe, the Middle East and Africa are up over 300% and over 150% in North America. Our Ekso Labs revenues increased over 40%. I am most proud that we now have tracked over 17 million steps taken in our Ekso medical devices, with an excellent safety record.”

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $212 million market valuation EKSO does have $25 million in the treasury, manageable debt and fast growing revenues. EKSO is one of the most exciting stocks in small caps with an eye on a bigger exchange. EKSO ability to raise capital proves just how real this Company is. We will be updating on EKSO when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with EKSO.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in EKSO either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.